Literature DB >> 17651842

The "slow coronary flow" phenomenon: evidence of preserved coronary flow reserve despite increased resting microvascular resistances.

Massimo Fineschi1, Achille Bravi, Tommaso Gori.   

Abstract

INTRODUCTION: The expression "slow coronary flow phenomenon" (SCFP) indicates a slow progression of the contrast seen at the coronary angiography in the absence of epicardial stenosis and/or of other conditions associated with decreased coronary flow velocity. While microvascular abnormalities are suspected to underlie the mechanism of SCFP, they have never been directly demonstrated. METHODS AND
RESULTS: Fifteen anginal patients with a positive stress test and no evidence of epicardial lesions (obstructive coronary artery disease, coronary ectasia, or coronary spasm) were enrolled. In eight patients, the diagnosis of SCFP was made (TIMI frame count>average +2SD). All subjects underwent measurement of the coronary flow reserve (CFR) and the index of microvascular resistance (IMR) using an intracoronary thermodilution method (RADI medical systems). There was no difference between groups in age, cardiovascular risk factors, blood pressure and heart rate, coronary artery diameter and fractional flow reserve (an index of the presence of epicardial stenosis). At rest, microvascular resistances (mean transit timexdistal pressure) were significantly higher in the SCFP group (SCFP: 104+/-31 versus 53+/-27, P<0.01). Showing normal responsiveness to vasodilators, this difference was abolished after induction of hyperemia (SCFP group: 34+/-22; control: 22+/-15, P=ns); coronary flow reserve was normal in the subjects with the SCFP (3.6+/-1.6).
CONCLUSIONS: We provide the first human in vivo evidence that resting microvascular resistances are increased in patients with the SCFP. At the same time, showing an intact capacity to vasodilate, microvascular resistances were normal during hyperemia, and coronary flow reserve was not impaired in SCFP patients.

Entities:  

Mesh:

Year:  2007        PMID: 17651842     DOI: 10.1016/j.ijcard.2007.06.010

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  22 in total

1.  Predictive Value of Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Patients with Coronary Slow Flow.

Authors:  Mustafa Çetin; Emrullah Kiziltunc; Özgül Uçar Elalmış; Zehra Güven Çetin; Muhammed Bora Demirçelik; Hülya Çiçekçioğlu; Alparslan Kurtul; Selçuk Özkan; Candan Mansuroğlu Avan; Ender Örnek; Feridun Vasfi Ulusoy
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

Review 2.  Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic Review.

Authors:  Federico Marchini; Graziella Pompei; Emanuele D'Aniello; Andrea Marrone; Serena Caglioni; Simone Biscaglia; Gianluca Campo; Matteo Tebaldi
Journal:  Cardiovasc Drugs Ther       Date:  2022-06-09       Impact factor: 3.727

3.  Coronary Slow Flow is Associated with Depression and Anxiety.

Authors:  Tahir Durmaz; Telat Keles; Kemal Esref Erdogan; Huseyin Ayhan; Emine Bilen; Nihal Akar Bayram; Murat Akcay; Ozgur Oz; Yakup Albayrak; Naci Ozdemir; Engin Bozkurt
Journal:  Acta Cardiol Sin       Date:  2014-05       Impact factor: 2.672

Review 4.  Coronary microvascular dysfunction in the clinical setting: from mystery to reality.

Authors:  Joerg Herrmann; Juan Carlos Kaski; Amir Lerman
Journal:  Eur Heart J       Date:  2012-08-22       Impact factor: 29.983

5.  Diverse spectrum of presentation of coronary slow flow phenomenon: a concise review of the literature.

Authors:  Muhammad A Chaudhry; Marcus Smith; Elias B Hanna; Ralph Lazzara
Journal:  Cardiol Res Pract       Date:  2012-05-08       Impact factor: 1.866

6.  Endothelial dysfunction and increased carotid intima-media thickness in the patients with slow coronary flow.

Authors:  Hyun Ju Yoon; Myung Ho Jeong; Sook Hee Cho; Kye Hun Kim; Min Goo Lee; Keun Ho Park; Doo Sun Sim; Nam Sik Yoon; Young Joon Hong; Ju Han Kim; Youngkeun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  J Korean Med Sci       Date:  2012-05-26       Impact factor: 2.153

7.  A randomized, single-center double-blinded trial on the effects of diltiazem sustained-release capsules in patients with coronary slow flow phenomenon at 6-month follow-up.

Authors:  Lun Li; Ye Gu; Tao Liu; Yupeng Bai; Lingbo Hou; Zhong Cheng; Liqun Hu; Bo Gao
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

8.  Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation.

Authors:  Andreas Goette; Alicja Bukowska; Christopher H Lillig; Uwe Lendeckel
Journal:  Front Physiol       Date:  2012-07-05       Impact factor: 4.566

9.  Nicorandil improves myocardial function by regulating plasma nitric oxide and endothelin-1 in coronary slow flow.

Authors:  Zuoyuan Chen; Xiuhua Chen; Shan Li; Xuezhen Huo; Xiuxiu Fu; Xiaonan Dong
Journal:  Coron Artery Dis       Date:  2015-03       Impact factor: 1.439

10.  Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles.

Authors:  Andreas Goette; Alicja Bukowska; Dobromir Dobrev; Jan Pfeiffenberger; Henning Morawietz; Denis Strugala; Ingrid Wiswedel; Friedrich-Wilhelm Röhl; Carmen Wolke; Sybille Bergmann; Peter Bramlage; Ursula Ravens; Uwe Lendeckel
Journal:  Eur Heart J       Date:  2009-03-05       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.